4.770SEK+1.60%Mkt Cap: 141.82M SEKP/E: —Last update: 2026-05-13
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy …
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-9.10
PEG—
P/B2.04
P/S9.98
EV/EBITDA-4.43
EV/Revenue8.83
EPS (TTM)-1.60
EPS (Forward)-0.50
Cash Flow & Leverage
FCF Yield-15.34%
FCF Margin-153.06%
Operating CF-31.20M SEK
CapEx (TTM)2.80M SEK
Net Debt/EBITDA0.46
Net Debt-13.04M SEK
Technical
SMA 504.657 (+2.4%)
SMA 2006.898 (-30.8%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)104.13K
Avg Vol (10d)189.59K
Technical Indicators
RSI (14)55.4
MACD-0.1615
MACD Signal-0.2754
MACD Hist.+0.1139
BB Upper5.334 SEK
BB Middle4.309 SEK
BB Lower3.283 SEK
BB Width47.59%
ATR (14)0.6080 SEK
Vol Ratio (20d)0.59x
52W Range
2.59020% of range13.36
52W High13.36 SEK
52W Low2.590 SEK
Profitability
Gross Margin62.44%
EBITDA Margin-199.10%
Profit Margin-237.96%
Oper. Margin-698.61%
ROE-59.73%
ROA-54.40%
Revenue Growth-69.50%
Earnings Growth—
Balance Sheet
Debt/Equity—
Current Ratio2.91
Quick Ratio1.56
Book Value/Sh2.235 SEK
Cash/Share0.4180 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:200
Split DateApr 25, 2024
Ownership
Shares Out.31.17M
Float27.80M
Insiders13.20%
Institutions4.45%
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)8.500 SEK
Target Range8.500 SEK – 8.500 SEK
# Analysts1
Company
Market Cap141.82M SEK
Enterprise Value125.50M SEK
Revenue (TTM)14.21M SEK
Gross Profit10.92M SEK
Net Income (TTM)-41.61M SEK
Revenue/Share0.6760 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
Last Price4.770 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—